Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study

E. Crocetti, L. Roche, C. Buzzoni, F. Di Costanzo, F. Molinié, A. Caldarella, Diego Serraino, Antonella Zucchetto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86% (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.
Original languageEnglish
Pages (from-to)S85-S91
Number of pages7
JournalEuropean Journal of Cancer Prevention
Volume26
Issue numbersupp 1
DOIs
Publication statusPublished - 2017

Fingerprint

Breast Neoplasms
Mortality
Population
Portugal
Belgium
Spain
France
Neoplasms
Delivery of Health Care
Switzerland
Early Detection of Cancer
Italy
Epidemiology
Language
Databases
Health

Keywords

  • Breast cancer
  • Cancer registries
  • Europe
  • Excess mortality rate
  • Latin countries
  • Net survival
  • Trend analysis
  • Article
  • Belgium
  • breast cancer
  • cancer epidemiology
  • cancer mortality
  • cancer patient
  • cancer registry
  • cancer survival
  • early cancer diagnosis
  • female
  • follow up
  • France
  • health care system
  • human
  • Italy
  • Portugal
  • priority journal
  • Spain
  • Switzerland

Cite this

Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study. / Crocetti, E.; Roche, L.; Buzzoni, C.; Di Costanzo, F.; Molinié, F.; Caldarella, A.; Serraino, Diego; Zucchetto, Antonella.

In: European Journal of Cancer Prevention, Vol. 26, No. supp 1, 2017, p. S85-S91.

Research output: Contribution to journalArticle

@article{d1fda0f0a1e943029b206707657c40fc,
title = "Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study",
abstract = "Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86{\%} (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment. Copyright {\circledC} 2017 Wolters Kluwer Health, Inc. All rights reserved.",
keywords = "Breast cancer, Cancer registries, Europe, Excess mortality rate, Latin countries, Net survival, Trend analysis, Article, Belgium, breast cancer, cancer epidemiology, cancer mortality, cancer patient, cancer registry, cancer survival, early cancer diagnosis, female, follow up, France, health care system, human, Italy, Portugal, priority journal, Spain, Switzerland",
author = "E. Crocetti and L. Roche and C. Buzzoni and {Di Costanzo}, F. and F. Molini{\'e} and A. Caldarella and Diego Serraino and Antonella Zucchetto",
note = "Export Date: 20 February 2018 CODEN: EJUPE Correspondence Address: Crocetti, E.; Romagna - Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, via Piero Maroncelli, 40, Italy; email: emanuelecrocetti@yahoo.com",
year = "2017",
doi = "10.1097/CEJ.0000000000000291",
language = "English",
volume = "26",
pages = "S85--S91",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "supp 1",

}

TY - JOUR

T1 - Trends in net survival from breast cancer in six European Latin countries: Results from the SUDCAN population-based study

AU - Crocetti, E.

AU - Roche, L.

AU - Buzzoni, C.

AU - Di Costanzo, F.

AU - Molinié, F.

AU - Caldarella, A.

AU - Serraino, Diego

AU - Zucchetto, Antonella

N1 - Export Date: 20 February 2018 CODEN: EJUPE Correspondence Address: Crocetti, E.; Romagna - Cancer Registry, Romagna Cancer Institute (IRST) IRCCS, via Piero Maroncelli, 40, Italy; email: emanuelecrocetti@yahoo.com

PY - 2017

Y1 - 2017

N2 - Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86% (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

AB - Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE. BC data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database. First, we focus on 1- and 5-year age-standardized net survival (NS) from BC by country over the 2000-2004 period. Then, trends in NS over the 1989-2004 period and changes in the pattern of cancer excess mortality rate (EMR) up to 5 years after diagnosis were examined using a multivariate EMR model. There were little differences in age-standardized NS from BC. Over the 2000-2004 period, the 5-year survival ranged between 82 (Spain, Belgium, and Portugal) and 86% (France). There was an increase in agestandardized survival between 1989 and 2004 at 1 year as well as at 5 years. This increase was observed at all ages and in all countries. There was a decrease in the cancer EMR both immediately after diagnosis and by the second and third year of follow-up. There were only minor differences in survival from BC between European Latin countries. The general improvement in NS is presumably because of advances in early cancer diagnosis and improvements in treatment. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.

KW - Breast cancer

KW - Cancer registries

KW - Europe

KW - Excess mortality rate

KW - Latin countries

KW - Net survival

KW - Trend analysis

KW - Article

KW - Belgium

KW - breast cancer

KW - cancer epidemiology

KW - cancer mortality

KW - cancer patient

KW - cancer registry

KW - cancer survival

KW - early cancer diagnosis

KW - female

KW - follow up

KW - France

KW - health care system

KW - human

KW - Italy

KW - Portugal

KW - priority journal

KW - Spain

KW - Switzerland

U2 - 10.1097/CEJ.0000000000000291

DO - 10.1097/CEJ.0000000000000291

M3 - Article

VL - 26

SP - S85-S91

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - supp 1

ER -